Results 11 to 20 of about 1,818,460 (375)

The Role of Elastography in Predicting the Grade of Mammary Ductal Carcinoma

The Iraqi Journal of Medical Sciences, 2022
Background: Elastography is an imaging technique which has been used in the last decades and its role in breast masses characterization is well established. However, its value for predicting breast cancer grading is yet to be studied. Objective:
Taimaa T.M. Said, Alaa Sheet, Bilal Nuaman   +2 more
doaj   +1 more source

Breast: Ductal carcinoma [PDF]

Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2013
Classification Invasive ductal carcinoma is a heterogeneous group with many different subtypes, some of them extremely rare. Each of these variants is associated with another pathological presentation and with a different prognosis compared to invasive ductal carcinoma of no special type (NST).
Moelans, CB, van, Diest PJ
openaire   +4 more sources

Ductal carcinoma in situ: to treat or not to treat, that is the question

British Journal of Cancer, 2019
Ductal carcinoma in situ (DCIS) now represents 20–25% of all ‘breast cancers’ consequent upon detection by population-based breast cancer screening programmes.
M. Seijen, E. Lips, A. Thompson, S. Nik-Zainal, A. Futreal, E. Hwang, E. Verschuur, J. Lane, J. Jonkers, D. Rea, J. Wesseling, J. Wesseling, Precision team   +12 more
semanticscholar   +1 more source

The shifting nature of women’s experiences and perceptions of ductal carcinoma in situ [PDF]

, 2011
Aim: This paper is a report of a descriptive qualitative study of the evolution of women’s perceptions and experiences of ductal carcinoma in situ from the period near to diagnosis to one year later.
Baum, Braun, Buick, Buick, Cady, Cameron, Carrera, Carrera, De Morgan, De Morgan, Dell, Erbas, Ernster, Evans, Fallowfield, Farmer, Fereday, Flick, Ganz, Godby, Goldsmith, Graff, Houghton, Janz, Kelly, Kennedy, Kennedy, Kennedy, Kennedy, Lauzier, Leonard, Leventhal, Leventhal, Mittra, Morrow, Napoles-Springer, Nekhlyudov, NHSBSP, NHSBSP, Oliffe, Partridge, Partridge, Prinjha, Rakovitch, Schmid-Buchi, Smith, Streubert, Teddlie, Ward, Webb, Wong, Ziebland   +51 more
core   +1 more source

Ductal carcinoma in situ

, 2012
Ductal carcinoma in situ (DCIS) represents a spectrum of abnormal cells confined to the breast and is a risk factor for invasive cancer development. The incidence has increased dramatically in recent years as a result of widespread use of screening mammography.
Nuran Bese, Ayfer Ay
  +5 more sources

Contralateral prophylactic mastectomies. Correlations between primary tumor and histological findings of controlateral breast [PDF]

, 2016
Backgound: In Italy in 2015 48,000 new cases of breast carcinomas were diagnosed. Women who are diagnosed with breast cancer have a significant risk of developing contralateral breast cancer during the rest of their lives and this risk is closely ...
Amanti, Claudio, Argento, Giuseppe, Campanella, L, Cunsolo, G, DI STEFANO, Domenica, Lombardi, Augusto, Maggi, Stefano, Mastrangeli, Mr, Mattei, Ms, Stanzani, G, Vitale, Valeria   +10 more
core   +1 more source

Potential biomarkers of ductal carcinoma in situ progression

BMC Cancer, 2020
Background Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment.
Raquel Spinassé Dettogni, Elaine Stur, Ana Carolina Laus, René Aloísio da Costa Vieira, Márcia Maria Chiquitelli Marques, Iara Viana Vidigal Santana, José Zago Pulido, Laura Fregonassi Ribeiro, Narelle de Jesus Parmanhani, Lidiane Pignaton Agostini, Raquel Silva dos Reis, Eldamária de Vargas Wolfgramm dos Santos, Lyvia Neves Rebello Alves, Fernanda Mariano Garcia, Jéssica Aflávio Santos, Diego do Prado Ventorim, Rui Manuel Reis, Iúri Drumond Louro   +17 more
doaj   +1 more source

Evaluation of a Novel Anti-Mucin 1 (MUC1) Antibody (PankoMab) as a Potential Diagnostic Tool in Human Ductal Breast Cancer; Comparison with Two Established Antibodies [PDF]

, 2009
Aim: PankoMab is a novel antibody that recognizes a tumor-specific epitope of Mucin 1 (MUC1). The aim of this study was the evaluation of PankoMab as a potential diagnostic tool and its comparison with two established antibodies against MUC1 in human ...
Dian, Darius, Friese, Klaus, Janni, Wolfgang, Jeschke, Udo, Karsten, Uwe, Kuhn, Christina, Mayr, Doris, Mylonas, Ioannis   +7 more
core   +1 more source

An Unusual Presentation of Extensive Ductal Carcinoma in Situ Accompanying Invasive Ductal Carcinoma on MRI: A Case Report

대한영상의학회지, 2022
The incidence of ductal carcinoma in situ has increased with the rise in screening mammography; currently, ductal carcinoma in situ constitutes 20%–25% of all breast cancers, and up to half of them may become invasive.
Yeon Jung Kim, Hyun Kyung Jung, Woogyeong Kim
doaj   +1 more source

Breast Ductal Carcinoma In Situ [PDF]

International Journal of Surgical Oncology, 2012
Ductal carcinoma in situ (DCIS) of the breast is becoming one of the most important diseases diagnosed in preventive medicine screening. The current age-adjusted incidence rate of DCIS is 32.5 per 100,000 women. For women 50–64 years of age, the incidence is approximately 88 per 100,000. Currently, for every 4 diagnoses of invasive breast cancer, there
V. Sacchini, L. Fortunato, H. S. Cody Iii, K. J. Van Zee, B. Cutuli, B. Bonanni   +5 more
openaire   +3 more sources